The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Prosthetic valve endocarditis after surgical and transcatheter aortic valve replacement: infrequent, but poor outcome

EuroIntervention 2019;15:e484-e485. DOI: 10.4244/EIJV15I6A88

1. Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands


Transcatheter aortic valve implantation (TAVI) has become an accepted alternative to surgical aortic valve replacement (SAVR). TAVI has been carefully evaluated in head-to-head comparisons in the PARTNER studies, with the most recent PARTNER 3 study (1,000 patients) showing that TAVI was superior to SAVR in preventing death, stroke and repeat hospitalisation at one-year follow-up1. Similarly, the EVOLUT Low Risk trial (1,403 patients) showed no difference in two-year outcomes (mortality, stroke) between SAVR and TAVI2. More importantly, in both trials, the one-year/two-year event rates were extremely low.

In addition to these “traditional events”, other events include development of valve ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus